Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy

Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy

Background Current treatment options for stage III non-small cell lung cancer (NSCLC) consist of different combinations of chemotherapy, surgery, radiotherapy and immunotherapy. Treatment choices are highly individual decisions, in which adverse events (AEs) are relevant for decision-making. This st...

Full description

Bibliographic Details
Main Authors: Thomas Iseli, Thierry Berghmans, Markus Glatzer, Achim Rittmeyer, Gilbert Massard, Valérie Durieux, Thomas Buchsbaum, Paul Martin Putora
Format: Article
Language:English
Published: European Respiratory Society 2020-09-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/6/3/00010-2020.full

Internet

http://openres.ersjournals.com/content/6/3/00010-2020.full

Similar Items